Hedge fund manager David Einhorn wrote a letter to clients saying "now there is a clear consensus that we are witnessing our second tech bubble in 15 years." Jim Iuorio, TJM Institutional Services, and Jeff Kilburg, KKM Financial, discuss.
The FMHR traders congratulate Anthony Scaramucci on his new baby boy, and reveal their final trades.
Dunkin' Donuts plans to open hundreds of new stores this year. CNBC's Jane Wells discusses if the company is expanding too far too fast.
Discussing what the deal between Amazon and HBO means to Netflix, with Michael Pachter, Wedbush Securities managing director of equity research.
CNBC's Simon Hobbs reports on all the market moving events in Europe today, including business activity nearing a 3-year high and euro zone debt hitting a record of 92.6% of GDP.
CNBC's Dominic Chu looks back at tech valuations at the peak of the Internet bubble 15 years ago and compares them to valuations today.
Jon Steinberg, BuzzFeed president & COO, discusses investor David Einhorn's comments that we are witnessing our second tech bubble in 15 years.
CNBC's Rick Santelli and Ed Lazear, former Council of Economic Advisors chairman, discuss the tax code system and the health of the U.S. economy.
Former Apple CEO John Sculley, discusses Apple innovation and if the DNA of Apple has changed under CEO Tim Cook. Sculley also weighs in on earnings expectations for the tech giant.
David Palmer, RBC Capital Markets managing director, breaks down Yum! Brands' Q1 earnings that missed on their top line and discusses the company's China business.
Kevin Caron, Stifel Private Client Group market strategist, and Doug MacKay, Broadleaf Partners president & CIO, discuss signs of a tech bubble and share their investment strategies on hot technology stocks.
CNBC's Mary Thompson looks at what's moving in early morning trading, including activity in P&G, Boeing and AT&T, as the Dow Transports nears all-time highs.
Don't trade Qualcomm off the earnings announcement, says CNBC's Jim Cramer.
Record sales of a new hepatitis C drug pushed the first-quarter earnings of Gilead Sciences beyond expectations. The "Squawk on the Street" news team break down its quarterly beat.
CNBC's Jim Cramer shares his thoughts on the legality of Bill Ackman's deal with Valeant to acquire Allergan, and why the SEC has an "existential crisis."
The bull market is seeing the equivalent of its first gray hairs and the proof is in Tuesday's blast of merger activity.
Paul Raines, GameStop CEO, discusses how its leadership in digital sales, market share, and ability to drive loyalty with rewards propels consumers to stay with the gaming store.
Mad Money host Jim Cramer breaks down the momentum many sectors saw in today's rally.
Discussing Xbox series "Every Street United" and pricing competition for original content, with Jonathan Weinbach, Mandalay Sports Media executive producer and senior vice president.
Mark Newton, Greywolf Execution Partners, looks at biotech's rebound and stabilization in the space.